title: Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients.
authors.affiliation: on behalf of Laura Calvillo, Carla Spazzolini, Eleonora Vullo, Roberto Insolia. Electronic address: peter.schwartz@unipv.it.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Schwartz
authors.affiliation: Laboratory of Cardiovascular Genetics and Center for Cardiac Arrhythmias of Genetic Origin, IRCCS Istituto Auxologico Italiano, Milan, Italy.
authors.forename: Lia
authors.initials: L
authors.lastname: Crotti
mesh_terms: D000818:Animals; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D004562:Electrocardiography / Q000187:drug effects*; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy*; D011433:Propranolol / Q000008:administration & dosage*
chemical_list: D011433:Propranolol